nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF1—melanoma	0.419	0.591	CbGaD
Pentosan Polysulfate—FGF2—melanoma	0.291	0.409	CbGaD
Pentosan Polysulfate—FGF4—appendage—melanoma	0.022	0.321	CbGeAlD
Pentosan Polysulfate—FGF1—dermis—melanoma	0.0115	0.168	CbGeAlD
Pentosan Polysulfate—FGF1—appendage—melanoma	0.00581	0.0848	CbGeAlD
Pentosan Polysulfate—FGF1—skin epidermis—melanoma	0.00483	0.0705	CbGeAlD
Pentosan Polysulfate—FGF4—head—melanoma	0.00369	0.054	CbGeAlD
Pentosan Polysulfate—FGF1—endothelium—melanoma	0.0035	0.0512	CbGeAlD
Pentosan Polysulfate—FGF1—blood vessel—melanoma	0.00323	0.0472	CbGeAlD
Pentosan Polysulfate—FGF2—eye—melanoma	0.00231	0.0338	CbGeAlD
Pentosan Polysulfate—FGF1—neck—melanoma	0.00231	0.0338	CbGeAlD
Pentosan Polysulfate—FGF2—mammalian vulva—melanoma	0.00183	0.0268	CbGeAlD
Pentosan Polysulfate—FGF1—eye—melanoma	0.00172	0.0251	CbGeAlD
Pentosan Polysulfate—Retinal haemorrhage—Carmustine—melanoma	0.00171	0.0358	CcSEcCtD
Pentosan Polysulfate—FGF1—retina—melanoma	0.0017	0.0249	CbGeAlD
Pentosan Polysulfate—FGF1—skin of body—melanoma	0.0015	0.0219	CbGeAlD
Pentosan Polysulfate—Raised liver function tests—Dactinomycin—melanoma	0.00129	0.027	CcSEcCtD
Pentosan Polysulfate—FGF1—head—melanoma	0.000976	0.0143	CbGeAlD
Pentosan Polysulfate—FGF2—lymph node—melanoma	0.000919	0.0134	CbGeAlD
Pentosan Polysulfate—Photosensitivity—Vemurafenib—melanoma	0.000869	0.0182	CcSEcCtD
Pentosan Polysulfate—Raised liver function tests—Docetaxel—melanoma	0.000774	0.0162	CcSEcCtD
Pentosan Polysulfate—Menorrhagia—Temozolomide—melanoma	0.000726	0.0152	CcSEcCtD
Pentosan Polysulfate—FGF1—lymph node—melanoma	0.000684	0.00998	CbGeAlD
Pentosan Polysulfate—Amenorrhoea—Temozolomide—melanoma	0.000611	0.0128	CcSEcCtD
Pentosan Polysulfate—Lacrimation—Docetaxel—melanoma	0.000608	0.0127	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Vemurafenib—melanoma	0.000602	0.0126	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Vemurafenib—melanoma	0.000597	0.0125	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Dactinomycin—melanoma	0.000543	0.0114	CcSEcCtD
Pentosan Polysulfate—Vaginal inflammation—Temozolomide—melanoma	0.000537	0.0113	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Dactinomycin—melanoma	0.000537	0.0113	CcSEcCtD
Pentosan Polysulfate—Vaginal infection—Temozolomide—melanoma	0.000507	0.0106	CcSEcCtD
Pentosan Polysulfate—Alopecia—Vemurafenib—melanoma	0.000466	0.00978	CcSEcCtD
Pentosan Polysulfate—Amenorrhoea—Docetaxel—melanoma	0.000407	0.00853	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Dactinomycin—melanoma	0.000398	0.00835	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Vemurafenib—melanoma	0.000391	0.00821	CcSEcCtD
Pentosan Polysulfate—Myalgia—Vemurafenib—melanoma	0.000391	0.00821	CcSEcCtD
Pentosan Polysulfate—Lacrimation increased—Docetaxel—melanoma	0.000388	0.00813	CcSEcCtD
Pentosan Polysulfate—Affect lability—Temozolomide—melanoma	0.000384	0.00805	CcSEcCtD
Pentosan Polysulfate—Infection—Vemurafenib—melanoma	0.000373	0.00782	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Carmustine—melanoma	0.000373	0.00781	CcSEcCtD
Pentosan Polysulfate—Mood swings—Temozolomide—melanoma	0.000369	0.00775	CcSEcCtD
Pentosan Polysulfate—Dehydration—Temozolomide—melanoma	0.000363	0.00761	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Bleomycin—melanoma	0.000361	0.00758	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Bleomycin—melanoma	0.000347	0.00728	CcSEcCtD
Pentosan Polysulfate—Colitis—Docetaxel—melanoma	0.000343	0.00719	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000342	0.00717	CcSEcCtD
Pentosan Polysulfate—Haematuria—Bleomycin—melanoma	0.00034	0.00713	CcSEcCtD
Pentosan Polysulfate—Sweating increased—Temozolomide—melanoma	0.000328	0.00689	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Docetaxel—melanoma	0.000326	0.00685	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Vemurafenib—melanoma	0.000326	0.00684	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Dactinomycin—melanoma	0.000324	0.00679	CcSEcCtD
Pentosan Polysulfate—Constipation—Vemurafenib—melanoma	0.000321	0.00673	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Temozolomide—melanoma	0.000311	0.00653	CcSEcCtD
Pentosan Polysulfate—Depression—Carmustine—melanoma	0.00031	0.0065	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Temozolomide—melanoma	0.000308	0.00645	CcSEcCtD
Pentosan Polysulfate—Weight increased—Temozolomide—melanoma	0.000307	0.00643	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Temozolomide—melanoma	0.000305	0.0064	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Carmustine—melanoma	0.000303	0.00636	CcSEcCtD
Pentosan Polysulfate—Depression—Temozolomide—melanoma	0.0003	0.00629	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Dactinomycin—melanoma	0.000296	0.00621	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Temozolomide—melanoma	0.000293	0.00614	CcSEcCtD
Pentosan Polysulfate—Alopecia—Bleomycin—melanoma	0.000283	0.00593	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Temozolomide—melanoma	0.000282	0.00591	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Vemurafenib—melanoma	0.000276	0.0058	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Temozolomide—melanoma	0.000268	0.00562	CcSEcCtD
Pentosan Polysulfate—Pruritus—Vemurafenib—melanoma	0.000265	0.00557	CcSEcCtD
Pentosan Polysulfate—Alopecia—Dactinomycin—melanoma	0.000264	0.00553	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Bleomycin—melanoma	0.000258	0.00542	CcSEcCtD
Pentosan Polysulfate—Anaemia—Bleomycin—melanoma	0.000257	0.0054	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Vemurafenib—melanoma	0.000257	0.00538	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Temozolomide—melanoma	0.000252	0.00528	CcSEcCtD
Pentosan Polysulfate—Malaise—Bleomycin—melanoma	0.000251	0.00527	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Bleomycin—melanoma	0.000249	0.00523	CcSEcCtD
Pentosan Polysulfate—Dizziness—Vemurafenib—melanoma	0.000248	0.0052	CcSEcCtD
Pentosan Polysulfate—Alopecia—Carmustine—melanoma	0.000247	0.00517	CcSEcCtD
Pentosan Polysulfate—Dehydration—Docetaxel—melanoma	0.000241	0.00506	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Dactinomycin—melanoma	0.000241	0.00505	CcSEcCtD
Pentosan Polysulfate—Anaemia—Dactinomycin—melanoma	0.00024	0.00503	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Docetaxel—melanoma	0.000239	0.00502	CcSEcCtD
Pentosan Polysulfate—Vomiting—Vemurafenib—melanoma	0.000238	0.005	CcSEcCtD
Pentosan Polysulfate—Alopecia—Temozolomide—melanoma	0.000238	0.005	CcSEcCtD
Pentosan Polysulfate—Myalgia—Bleomycin—melanoma	0.000237	0.00497	CcSEcCtD
Pentosan Polysulfate—Rash—Vemurafenib—melanoma	0.000236	0.00496	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Vemurafenib—melanoma	0.000236	0.00496	CcSEcCtD
Pentosan Polysulfate—Headache—Vemurafenib—melanoma	0.000235	0.00493	CcSEcCtD
Pentosan Polysulfate—Discomfort—Bleomycin—melanoma	0.000234	0.00491	CcSEcCtD
Pentosan Polysulfate—Malaise—Dactinomycin—melanoma	0.000234	0.00491	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Dactinomycin—melanoma	0.000232	0.00488	CcSEcCtD
Pentosan Polysulfate—Oedema—Bleomycin—melanoma	0.000227	0.00477	CcSEcCtD
Pentosan Polysulfate—Infection—Bleomycin—melanoma	0.000226	0.00473	CcSEcCtD
Pentosan Polysulfate—Anaemia—Carmustine—melanoma	0.000225	0.00471	CcSEcCtD
Pentosan Polysulfate—Agitation—Carmustine—melanoma	0.000223	0.00468	CcSEcCtD
Pentosan Polysulfate—Nausea—Vemurafenib—melanoma	0.000223	0.00467	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Bleomycin—melanoma	0.000222	0.00467	CcSEcCtD
Pentosan Polysulfate—Myalgia—Dactinomycin—melanoma	0.000221	0.00464	CcSEcCtD
Pentosan Polysulfate—Discomfort—Dactinomycin—melanoma	0.000218	0.00458	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Docetaxel—melanoma	0.000218	0.00458	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Temozolomide—melanoma	0.000218	0.00457	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Carmustine—melanoma	0.000218	0.00456	CcSEcCtD
Pentosan Polysulfate—Anaemia—Temozolomide—melanoma	0.000217	0.00455	CcSEcCtD
Pentosan Polysulfate—Anorexia—Bleomycin—melanoma	0.000217	0.00454	CcSEcCtD
Pentosan Polysulfate—Agitation—Temozolomide—melanoma	0.000216	0.00453	CcSEcCtD
Pentosan Polysulfate—Oedema—Dactinomycin—melanoma	0.000212	0.00444	CcSEcCtD
Pentosan Polysulfate—Malaise—Temozolomide—melanoma	0.000212	0.00444	CcSEcCtD
Pentosan Polysulfate—Infection—Dactinomycin—melanoma	0.000211	0.00442	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Temozolomide—melanoma	0.00021	0.00441	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Dactinomycin—melanoma	0.000207	0.00435	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Bleomycin—melanoma	0.000207	0.00434	CcSEcCtD
Pentosan Polysulfate—Myalgia—Carmustine—melanoma	0.000207	0.00434	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Bleomycin—melanoma	0.000204	0.00428	CcSEcCtD
Pentosan Polysulfate—Weight increased—Docetaxel—melanoma	0.000204	0.00428	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Docetaxel—melanoma	0.000203	0.00425	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Bleomycin—melanoma	0.000203	0.00425	CcSEcCtD
Pentosan Polysulfate—Anorexia—Dactinomycin—melanoma	0.000202	0.00424	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Temozolomide—melanoma	0.0002	0.00419	CcSEcCtD
Pentosan Polysulfate—Myalgia—Temozolomide—melanoma	0.0002	0.00419	CcSEcCtD
Pentosan Polysulfate—Oedema—Carmustine—melanoma	0.000198	0.00416	CcSEcCtD
Pentosan Polysulfate—Discomfort—Temozolomide—melanoma	0.000198	0.00414	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Bleomycin—melanoma	0.000198	0.00414	CcSEcCtD
Pentosan Polysulfate—Infection—Carmustine—melanoma	0.000197	0.00413	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Docetaxel—melanoma	0.000195	0.00409	CcSEcCtD
Pentosan Polysulfate—Jaundice—Docetaxel—melanoma	0.000195	0.00409	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Docetaxel—melanoma	0.000194	0.00407	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Carmustine—melanoma	0.000194	0.00407	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000193	0.00405	CcSEcCtD
Pentosan Polysulfate—Oedema—Temozolomide—melanoma	0.000192	0.00402	CcSEcCtD
Pentosan Polysulfate—Infection—Temozolomide—melanoma	0.00019	0.00399	CcSEcCtD
Pentosan Polysulfate—Anorexia—Carmustine—melanoma	0.000189	0.00397	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Docetaxel—melanoma	0.000188	0.00395	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Temozolomide—melanoma	0.000188	0.00394	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Bleomycin—melanoma	0.000187	0.00393	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Temozolomide—melanoma	0.000185	0.00389	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Dactinomycin—melanoma	0.000184	0.00386	CcSEcCtD
Pentosan Polysulfate—Anorexia—Temozolomide—melanoma	0.000183	0.00383	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Carmustine—melanoma	0.000181	0.00379	CcSEcCtD
Pentosan Polysulfate—Urticaria—Bleomycin—melanoma	0.00018	0.00379	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Docetaxel—melanoma	0.00018	0.00377	CcSEcCtD
Pentosan Polysulfate—Insomnia—Carmustine—melanoma	0.000179	0.00376	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Carmustine—melanoma	0.000178	0.00374	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Docetaxel—melanoma	0.000178	0.00373	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Carmustine—melanoma	0.000177	0.00371	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Dactinomycin—melanoma	0.000175	0.00366	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Temozolomide—melanoma	0.000175	0.00366	CcSEcCtD
Pentosan Polysulfate—Insomnia—Temozolomide—melanoma	0.000173	0.00364	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Dactinomycin—melanoma	0.000173	0.00363	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Carmustine—melanoma	0.000172	0.00362	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Temozolomide—melanoma	0.000172	0.00361	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Temozolomide—melanoma	0.000171	0.00358	CcSEcCtD
Pentosan Polysulfate—Constipation—Carmustine—melanoma	0.00017	0.00356	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Temozolomide—melanoma	0.000169	0.00354	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Dactinomycin—melanoma	0.000168	0.00351	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Bleomycin—melanoma	0.000167	0.00351	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Temozolomide—melanoma	0.000167	0.00349	CcSEcCtD
Pentosan Polysulfate—Constipation—Temozolomide—melanoma	0.000164	0.00344	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Carmustine—melanoma	0.000163	0.00343	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Carmustine—melanoma	0.000162	0.0034	CcSEcCtD
Pentosan Polysulfate—Pruritus—Bleomycin—melanoma	0.000161	0.00337	CcSEcCtD
Pentosan Polysulfate—Alopecia—Docetaxel—melanoma	0.000159	0.00333	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Temozolomide—melanoma	0.000158	0.00331	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Carmustine—melanoma	0.000157	0.00329	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Temozolomide—melanoma	0.000157	0.00329	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Dactinomycin—melanoma	0.000156	0.00327	CcSEcCtD
Pentosan Polysulfate—Urticaria—Temozolomide—melanoma	0.000152	0.00319	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Temozolomide—melanoma	0.000152	0.00318	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Carmustine—melanoma	0.000146	0.00307	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Dactinomycin—melanoma	0.000145	0.00304	CcSEcCtD
Pentosan Polysulfate—Vomiting—Bleomycin—melanoma	0.000144	0.00303	CcSEcCtD
Pentosan Polysulfate—Anaemia—Docetaxel—melanoma	0.000144	0.00303	CcSEcCtD
Pentosan Polysulfate—Rash—Bleomycin—melanoma	0.000143	0.00301	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Bleomycin—melanoma	0.000143	0.003	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Temozolomide—melanoma	0.000141	0.00296	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Docetaxel—melanoma	0.00014	0.00293	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Carmustine—melanoma	0.000136	0.00285	CcSEcCtD
Pentosan Polysulfate—Pruritus—Temozolomide—melanoma	0.000136	0.00284	CcSEcCtD
Pentosan Polysulfate—Nausea—Bleomycin—melanoma	0.000135	0.00283	CcSEcCtD
Pentosan Polysulfate—Vomiting—Dactinomycin—melanoma	0.000135	0.00283	CcSEcCtD
Pentosan Polysulfate—Rash—Dactinomycin—melanoma	0.000134	0.0028	CcSEcCtD
Pentosan Polysulfate—Myalgia—Docetaxel—melanoma	0.000133	0.00279	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Docetaxel—melanoma	0.000133	0.00279	CcSEcCtD
Pentosan Polysulfate—Dizziness—Carmustine—melanoma	0.000131	0.00275	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Temozolomide—melanoma	0.000131	0.00275	CcSEcCtD
Pentosan Polysulfate—Oedema—Docetaxel—melanoma	0.000127	0.00267	CcSEcCtD
Pentosan Polysulfate—Dizziness—Temozolomide—melanoma	0.000127	0.00266	CcSEcCtD
Pentosan Polysulfate—Infection—Docetaxel—melanoma	0.000127	0.00266	CcSEcCtD
Pentosan Polysulfate—Vomiting—Carmustine—melanoma	0.000126	0.00265	CcSEcCtD
Pentosan Polysulfate—Nausea—Dactinomycin—melanoma	0.000126	0.00264	CcSEcCtD
Pentosan Polysulfate—Rash—Carmustine—melanoma	0.000125	0.00262	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Carmustine—melanoma	0.000125	0.00262	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Docetaxel—melanoma	0.000125	0.00262	CcSEcCtD
Pentosan Polysulfate—Headache—Carmustine—melanoma	0.000124	0.00261	CcSEcCtD
Pentosan Polysulfate—Vomiting—Temozolomide—melanoma	0.000122	0.00256	CcSEcCtD
Pentosan Polysulfate—Anorexia—Docetaxel—melanoma	0.000121	0.00255	CcSEcCtD
Pentosan Polysulfate—Rash—Temozolomide—melanoma	0.000121	0.00253	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Temozolomide—melanoma	0.000121	0.00253	CcSEcCtD
Pentosan Polysulfate—Headache—Temozolomide—melanoma	0.00012	0.00252	CcSEcCtD
Pentosan Polysulfate—Nausea—Carmustine—melanoma	0.000118	0.00247	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Docetaxel—melanoma	0.000116	0.00244	CcSEcCtD
Pentosan Polysulfate—Insomnia—Docetaxel—melanoma	0.000115	0.00242	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Docetaxel—melanoma	0.000114	0.0024	CcSEcCtD
Pentosan Polysulfate—Nausea—Temozolomide—melanoma	0.000114	0.00239	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Docetaxel—melanoma	0.000114	0.00238	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Docetaxel—melanoma	0.000112	0.00235	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Docetaxel—melanoma	0.000111	0.00232	CcSEcCtD
Pentosan Polysulfate—Constipation—Docetaxel—melanoma	0.000109	0.00229	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Docetaxel—melanoma	0.000105	0.0022	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Docetaxel—melanoma	0.000104	0.00219	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Docetaxel—melanoma	0.000101	0.00211	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Docetaxel—melanoma	9.39e-05	0.00197	CcSEcCtD
Pentosan Polysulfate—Pruritus—Docetaxel—melanoma	9.02e-05	0.00189	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Docetaxel—melanoma	8.72e-05	0.00183	CcSEcCtD
Pentosan Polysulfate—Dizziness—Docetaxel—melanoma	8.43e-05	0.00177	CcSEcCtD
Pentosan Polysulfate—Vomiting—Docetaxel—melanoma	8.1e-05	0.0017	CcSEcCtD
Pentosan Polysulfate—Rash—Docetaxel—melanoma	8.04e-05	0.00169	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Docetaxel—melanoma	8.03e-05	0.00168	CcSEcCtD
Pentosan Polysulfate—Headache—Docetaxel—melanoma	7.98e-05	0.00167	CcSEcCtD
Pentosan Polysulfate—Nausea—Docetaxel—melanoma	7.57e-05	0.00159	CcSEcCtD
Pentosan Polysulfate—FGF2—Disease—EGF—melanoma	7.06e-06	4.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ITGB3—melanoma	7e-06	4.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PRKCA—melanoma	7e-06	4.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MAPK3—melanoma	6.98e-06	4.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MAP2K1—melanoma	6.93e-06	3.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CD—melanoma	6.89e-06	3.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CD86—melanoma	6.87e-06	3.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SPP1—melanoma	6.87e-06	3.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—EGFR—melanoma	6.86e-06	3.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MAP2K1—melanoma	6.85e-06	3.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAP2K2—melanoma	6.85e-06	3.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EDN1—melanoma	6.81e-06	3.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MDM2—melanoma	6.8e-06	3.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—PIK3CA—melanoma	6.8e-06	3.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CD—melanoma	6.8e-06	3.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—KRAS—melanoma	6.79e-06	3.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MYC—melanoma	6.79e-06	3.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—BCL2—melanoma	6.78e-06	3.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—KRAS—melanoma	6.75e-06	3.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IFNG—melanoma	6.72e-06	3.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—BRAF—melanoma	6.71e-06	3.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ERBB2—melanoma	6.71e-06	3.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MDM2—melanoma	6.68e-06	3.83e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CSF2—melanoma	6.66e-06	3.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FGF1—melanoma	6.66e-06	3.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MAPK1—melanoma	6.64e-06	3.81e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—EGFR—melanoma	6.64e-06	3.81e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CB—melanoma	6.62e-06	3.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—FGF2—melanoma	6.59e-06	3.78e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—ERBB2—melanoma	6.59e-06	3.78e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—PIK3CA—melanoma	6.53e-06	3.75e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—E2F1—melanoma	6.52e-06	3.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TERT—melanoma	6.51e-06	3.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CB—melanoma	6.5e-06	3.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—HRAS—melanoma	6.5e-06	3.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RAC1—melanoma	6.49e-06	3.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CD4—melanoma	6.49e-06	3.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KRAS—melanoma	6.48e-06	3.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PDGFRA—melanoma	6.45e-06	3.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PRKCA—melanoma	6.39e-06	3.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ITGB3—melanoma	6.39e-06	3.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CXCL8—melanoma	6.36e-06	3.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MAP2K1—melanoma	6.32e-06	3.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—HRAS—melanoma	6.29e-06	3.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CD—melanoma	6.28e-06	3.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—KRAS—melanoma	6.27e-06	3.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SPP1—melanoma	6.26e-06	3.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—PIK3CA—melanoma	6.24e-06	3.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAP2K2—melanoma	6.24e-06	3.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HIF1A—melanoma	6.23e-06	3.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—IL6—melanoma	6.22e-06	3.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CDKN1B—melanoma	6.21e-06	3.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—PIK3CA—melanoma	6.2e-06	3.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—BCL2—melanoma	6.18e-06	3.55e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MDM2—melanoma	6.17e-06	3.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IFNG—melanoma	6.13e-06	3.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDKN1B—melanoma	6.1e-06	3.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MDM2—melanoma	6.09e-06	3.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CASP3—melanoma	6.09e-06	3.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—ERBB2—melanoma	6.08e-06	3.49e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL2—melanoma	6.08e-06	3.49e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—HRAS—melanoma	6.04e-06	3.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—IL6—melanoma	6.02e-06	3.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ERBB2—melanoma	6.01e-06	3.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CB—melanoma	6e-06	3.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CD4—melanoma	5.99e-06	3.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL2—melanoma	5.97e-06	3.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—PIK3CA—melanoma	5.96e-06	3.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KDR—melanoma	5.95e-06	3.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTGS2—melanoma	5.95e-06	3.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TERT—melanoma	5.94e-06	3.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCND1—melanoma	5.93e-06	3.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CB—melanoma	5.93e-06	3.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RAC1—melanoma	5.92e-06	3.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD4—melanoma	5.92e-06	3.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CTNNB1—melanoma	5.87e-06	3.37e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—HRAS—melanoma	5.78e-06	3.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PIK3CA—melanoma	5.76e-06	3.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CTNNB1—melanoma	5.76e-06	3.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MMP9—melanoma	5.75e-06	3.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—HRAS—melanoma	5.74e-06	3.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—AKT1—melanoma	5.74e-06	3.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CDKN1A—melanoma	5.73e-06	3.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FN1—melanoma	5.73e-06	3.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PTEN—melanoma	5.72e-06	3.28e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NFKB1—melanoma	5.69e-06	3.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HIF1A—melanoma	5.68e-06	3.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CDKN1B—melanoma	5.63e-06	3.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDKN1A—melanoma	5.63e-06	3.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MDM2—melanoma	5.62e-06	3.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PTEN—melanoma	5.62e-06	3.22e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NOTCH1—melanoma	5.61e-06	3.22e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—NFKB1—melanoma	5.59e-06	3.21e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDKN1B—melanoma	5.56e-06	3.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—AKT1—melanoma	5.56e-06	3.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ERBB2—melanoma	5.55e-06	3.18e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL6—melanoma	5.53e-06	3.17e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—HRAS—melanoma	5.51e-06	3.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CD80—melanoma	5.49e-06	3.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—IL6—melanoma	5.49e-06	3.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KIT—melanoma	5.48e-06	3.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CG—melanoma	5.48e-06	3.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APC—melanoma	5.48e-06	3.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CB—melanoma	5.47e-06	3.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CD4—melanoma	5.46e-06	3.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL2—melanoma	5.44e-06	3.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KDR—melanoma	5.43e-06	3.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTGS2—melanoma	5.42e-06	3.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EGF—melanoma	5.42e-06	3.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—AKT1—melanoma	5.34e-06	3.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—HRAS—melanoma	5.33e-06	3.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CTNNB1—melanoma	5.32e-06	3.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CTNNB1—melanoma	5.26e-06	3.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FN1—melanoma	5.23e-06	3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CDKN1A—melanoma	5.2e-06	2.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTEN—melanoma	5.19e-06	2.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—VEGFA—melanoma	5.17e-06	2.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—BRAF—melanoma	5.16e-06	2.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CDKN1B—melanoma	5.14e-06	2.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDKN1A—melanoma	5.13e-06	2.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PTEN—melanoma	5.12e-06	2.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—STAT3—melanoma	5.12e-06	2.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NOTCH1—melanoma	5.11e-06	2.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NRAS—melanoma	5.1e-06	2.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—IL6—melanoma	5.1e-06	2.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—AKT1—melanoma	5.1e-06	2.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—NFKB1—melanoma	5.1e-06	2.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—AKT1—melanoma	5.07e-06	2.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—STAT3—melanoma	5.02e-06	2.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IGF1—melanoma	5.02e-06	2.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—NRAS—melanoma	5.01e-06	2.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CD80—melanoma	5.01e-06	2.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APC—melanoma	5e-06	2.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KIT—melanoma	5e-06	2.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CG—melanoma	5e-06	2.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EGF—melanoma	4.94e-06	2.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MAPK3—melanoma	4.89e-06	2.81e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—AKT1—melanoma	4.87e-06	2.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAP2K1—melanoma	4.85e-06	2.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CTNNB1—melanoma	4.85e-06	2.78e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CD—melanoma	4.82e-06	2.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MAPK3—melanoma	4.8e-06	2.75e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MYC—melanoma	4.75e-06	2.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CDKN1A—melanoma	4.74e-06	2.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTEN—melanoma	4.73e-06	2.71e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—AKT1—melanoma	4.71e-06	2.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—BRAF—melanoma	4.7e-06	2.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MAPK1—melanoma	4.65e-06	2.67e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EGFR—melanoma	4.65e-06	2.67e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—STAT3—melanoma	4.64e-06	2.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NRAS—melanoma	4.63e-06	2.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FGF2—melanoma	4.62e-06	2.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—STAT3—melanoma	4.58e-06	2.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IGF1—melanoma	4.58e-06	2.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—NRAS—melanoma	4.57e-06	2.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MAPK1—melanoma	4.57e-06	2.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EGFR—melanoma	4.57e-06	2.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MAPK3—melanoma	4.43e-06	2.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAP2K1—melanoma	4.43e-06	2.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CD—melanoma	4.4e-06	2.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KRAS—melanoma	4.39e-06	2.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MAPK3—melanoma	4.38e-06	2.51e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MDM2—melanoma	4.32e-06	2.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KRAS—melanoma	4.31e-06	2.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MYC—melanoma	4.31e-06	2.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ERBB2—melanoma	4.26e-06	2.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—STAT3—melanoma	4.23e-06	2.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NRAS—melanoma	4.22e-06	2.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MAPK1—melanoma	4.22e-06	2.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EGFR—melanoma	4.22e-06	2.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CB—melanoma	4.2e-06	2.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MAPK1—melanoma	4.16e-06	2.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EGFR—melanoma	4.16e-06	2.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MAPK3—melanoma	4.04e-06	2.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CXCL8—melanoma	4.04e-06	2.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CA—melanoma	4.04e-06	2.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—KRAS—melanoma	3.98e-06	2.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CA—melanoma	3.96e-06	2.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDKN1B—melanoma	3.94e-06	2.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MDM2—melanoma	3.94e-06	2.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KRAS—melanoma	3.93e-06	2.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MYC—melanoma	3.93e-06	2.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TP53—melanoma	3.9e-06	2.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ERBB2—melanoma	3.88e-06	2.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CASP3—melanoma	3.87e-06	2.22e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL2—melanoma	3.86e-06	2.22e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MAPK1—melanoma	3.84e-06	2.21e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EGFR—melanoma	3.84e-06	2.21e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CB—melanoma	3.83e-06	2.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCND1—melanoma	3.76e-06	2.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HRAS—melanoma	3.73e-06	2.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CTNNB1—melanoma	3.73e-06	2.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCL8—melanoma	3.68e-06	2.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—HRAS—melanoma	3.67e-06	2.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CA—melanoma	3.66e-06	2.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MMP9—melanoma	3.65e-06	2.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDKN1A—melanoma	3.64e-06	2.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PTEN—melanoma	3.63e-06	2.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KRAS—melanoma	3.63e-06	2.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NFKB1—melanoma	3.61e-06	2.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CA—melanoma	3.61e-06	2.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDKN1B—melanoma	3.6e-06	2.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL6—melanoma	3.57e-06	2.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CASP3—melanoma	3.52e-06	2.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL2—melanoma	3.52e-06	2.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL6—melanoma	3.51e-06	2.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCND1—melanoma	3.43e-06	1.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CTNNB1—melanoma	3.4e-06	1.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HRAS—melanoma	3.38e-06	1.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HRAS—melanoma	3.34e-06	1.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CA—melanoma	3.34e-06	1.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MMP9—melanoma	3.33e-06	1.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDKN1A—melanoma	3.32e-06	1.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTEN—melanoma	3.31e-06	1.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AKT1—melanoma	3.3e-06	1.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NFKB1—melanoma	3.3e-06	1.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VEGFA—melanoma	3.28e-06	1.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—STAT3—melanoma	3.25e-06	1.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NRAS—melanoma	3.24e-06	1.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—IL6—melanoma	3.24e-06	1.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—AKT1—melanoma	3.24e-06	1.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL6—melanoma	3.2e-06	1.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAPK3—melanoma	3.1e-06	1.78e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HRAS—melanoma	3.09e-06	1.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MYC—melanoma	3.02e-06	1.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VEGFA—melanoma	2.99e-06	1.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—AKT1—melanoma	2.99e-06	1.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—STAT3—melanoma	2.96e-06	1.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NRAS—melanoma	2.95e-06	1.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IL6—melanoma	2.95e-06	1.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAPK1—melanoma	2.95e-06	1.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—AKT1—melanoma	2.95e-06	1.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EGFR—melanoma	2.95e-06	1.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAPK3—melanoma	2.83e-06	1.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KRAS—melanoma	2.79e-06	1.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MYC—melanoma	2.75e-06	1.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—AKT1—melanoma	2.73e-06	1.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAPK1—melanoma	2.69e-06	1.55e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EGFR—melanoma	2.69e-06	1.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CA—melanoma	2.56e-06	1.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KRAS—melanoma	2.54e-06	1.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TP53—melanoma	2.48e-06	1.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HRAS—melanoma	2.37e-06	1.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CA—melanoma	2.34e-06	1.34e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL6—melanoma	2.27e-06	1.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TP53—melanoma	2.26e-06	1.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HRAS—melanoma	2.16e-06	1.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKT1—melanoma	2.09e-06	1.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL6—melanoma	2.07e-06	1.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKT1—melanoma	1.91e-06	1.1e-05	CbGpPWpGaD
